Clinical trial NCT06570746: "Comparison of the Effectiveness of Conventional Radiofrequency Thermocoagulation and Chemical Ablation With Phenol on Articular Branches of Femoral and Obturator Nerves in Chronic Hip Pain"
Official title: "Comparison of the Effectiveness of Conventional Radiofrequency Thermocoagulation and Chemical Ablation With Phenol on Articular Branches of Femoral and Obturator Nerves in Chronic Hip Pain"
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: NA
Conditions: Chronic Pain
Keywords: Radiofrequency thermocoagulation
Phenol chemical ablation
Lead sponsor: Aydin Adnan Menderes University
Sponsor class: OTHER
First posted: 2024-08-26
Enrollment: 48
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: TREATMENT

Brief summary: "In our study, we aimed to compare the effects of conventional radiofrequency thermocoagulation applied to the articular branches of the femoral and obturator nerves with chemical ablation using phenol on hip pain."

Detailed description: "Our study is designed as a double-blind, prospective randomized controlled trial. Blinding will be ensured by keeping the researcher performing pain diary follow-ups unaware of which procedure was applied to each patient.

Patients will be randomized using computer-assisted methods. Following approval from the hospital ethics committee, clinical trial registration will be conducted. From 2024 to 2025, patients presenting with chronic hip pain to the Department of Algology at ADU Faculty of Medicine will be divided into two groups. In Group 1, chemical ablation of the femoral and obturator nerve branches with phenol under ultrasound guidance will be performed. In Group 2, conventional radiofrequency thermocoagulation of the articular branches of the femoral and obturator nerves under ultrasound guidance will be applied.

During the study, pain intensity will be assessed using the Numerical Rating Scale (NRS) at baseline, 2 hours post-procedure, and at 1 month and 3 months post-procedure for both Group 1 and Group 2. The WOMAC scale will be used to evaluate their functional capacity."

Eligibility criteria: Inclusion Criteria:

Be older than 18 years old. Written consent must be obtained. Have had chronic hip pain for more than 3 weeks. -

Exclusion Criteria:

Major psychiatric illness Presence of lumbar radicular pain or referred pain in the patient Patients using anticoagulant agents Patients with infection in the area where the procedure will be performed Those with allergy to local anesthetics Those allergic to phenol or betamethasone Pregnant women Scheduled for surgery

-

Primary outcomes:
measure: NRS (Numerical Rating Scale)
timeFrame: preoperative
measure: NRS (Numerical Rating Scale)
timeFrame: postoperative first month
measure: NRS (Numerical Rating Scale)
timeFrame: postoperative third month
Secondary outcomes:
measure: WOMAC (Western OntarioandMcMasterUniversitiesArthritis Index )
timeFrame: preoperative
measure: WOMAC (Western OntarioandMcMasterUniversitiesArthritis Index )
timeFrame: postoperative first month
measure: WOMAC (Western OntarioandMcMasterUniversitiesArthritis Index )
timeFrame: postoperative third month
Other outcomes:
Locations:
city: Aydın
country: Turkey
facility: Adnan Menderes University Faculty of Medicine
Study officials:
affiliation: Aydin Adnan Menderes University
name: akylai dosieva
role: PRINCIPAL_INVESTIGATOR
References: